Cell bioreactor

By applying a positively charged cell adhesion layer on the inner surface of the hollow fiber membrane of the cell bioreactor and optimizing the plasma inlet and outlet settings, the problem of hepatocyte accumulation is solved, and the uniform distribution of hepatocytes and toxin treatment efficiency are improved.

CN222064571UActive Publication Date: 2024-11-26SHANDONG WEIGAO BLOOD PURIFICATION PRODUCTS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202323638126.5
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-28
Publication Date
2024-11-26
Estimated Expiration
2033-12-28

AI Technical Summary

Technical Problem

In cell bioreactors, hepatocytes tend to accumulate at the bottom of the shell, resulting in uneven distribution, affecting the stability of growth and culture and the efficiency of toxin treatment.

Method used

Design a cell bioreactor in which the inner surface of the hollow fiber membrane is coated with a positively charged cell adhesion layer, which drives the uniform distribution of liver cells through the pump body, and optimizes plasma and liver cells through the settings of plasma inlet and waste liquid outlet material exchange to avoid hepatocyte accumulation and shell interference.

Benefits of technology

The uniform distribution and growth of liver cells is achieved, the stability of growth and culture and the efficiency of toxin treatment are improved, and the mutual interference between liver cells and shell and membrane bundle is avoided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222064571U_ABST
    Figure CN222064571U_ABST
Patent Text Reader

Abstract

The utility model discloses a cell bioreactor and relates to the technical field of medical equipment. The cell bioreactor comprises a reactor body, the reactor body comprises a shell and a hollow fiber membrane, and the inner surface of the hollow fiber membrane is provided with a positively charged cell adhesion layer; a cell inlet is formed in the bottom of the shell, a cell outlet is formed in the top of the shell, the cell outlet and the cell inlet are in butt joint with an inner cavity of the hollow fiber membrane, the cell inlet is connected with a cell supply container, a first pump is arranged on the cell supply container, and the cell outlet is connected with a cell receiving container; the side wall of the shell is provided with a plasma inlet and a waste liquid outlet which are butted with the outer cavity of the hollow fiber membrane, and the plasma inlet is connected with a plasma container; the cell supply container can supply hepatocytes to the inner cavity, and the cell adhesion layer attracts the hepatocytes to adhere to the surface of the hollow fiber membrane, so that the hepatocytes can be uniformly distributed and are prevented from being accumulated at the bottom of the shell, and the growth and culture stability of the hepatocytes and the toxin treatment effect and efficiency are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical equipment, in particular to a cell bioreactor. Background Art

[0002] An existing cell bioreactor includes an outer shell and a hollow fiber membrane in the outer shell, which can be used for bioartificial liver treatment. The hollow fiber membrane is divided into an inner cavity and an outer cavity, and the hollow fiber membrane is a semipermeable membrane. The hepatocytes in the outer cavity and the plasma in the inner cavity can perform two-way plasma transmission and biological action with the help of the semipermeable membrane. The inner cavity contains plasma with toxins, and the plasma and hepatocytes can perform two-way plasma transmission and biological action with the help of the semipermeable membrane, thereby completing the treatment and allowing the hepatocytes to obtain nutrients and oxygen.

[0003] However, after placing hepatocytes in a cell bioreactor, the hepatocytes tend to accumulate at the bottom of the shell of the cell bioreactor and be unevenly distributed, affecting the vitality and function of the hepatocytes, thereby affecting the stability of hepatocyte growth and culture, as well as the effect and efficiency of toxin treatment.

[0004] Therefore, how to improve the stability of hepatocyte growth and culture, as well as the effect and efficiency of toxin treatment, is a technical problem that technicians in this field currently need to solve. Utility Model Content

[0005] In view of this, the purpose of the utility model is to provide a cell bioreactor, which can improve the stability of liver cell growth and culture, as well as the effect and efficiency of toxin treatment.

[0006] In order to achieve the above purpose, the utility model provides the following technical solutions:

[0007] A cell bioreactor comprises a reactor body, wherein the reactor body comprises an outer shell and a hollow fiber membrane arranged in the outer shell, wherein the inner surface of the hollow fiber membrane has a positively charged cell adhesion layer; a cell inlet is arranged at the bottom of the outer shell, and a cell outlet is arranged at the top, wherein the cell outlet and the cell inlet are both connected to the inner cavity of the hollow fiber membrane, the cell inlet is connected to a cell supply container, a first pump body is arranged on the cell supply container, and the cell outlet is connected to a cell receiving container; a plasma inlet and a waste liquid outlet are arranged on the side wall of the outer shell and are connected to the outer cavity of the hollow fiber membrane, wherein the plasma inlet is connected to the plasma container, and the waste liquid outlet is connected to the waste liquid container.

[0008] Preferably, the cell adhesion layer is a chitosan layer.

[0009] Preferably, the waste liquid outlet is lower than the plasma inlet.

[0010] Preferably, the shell has a first side wall and a second side wall opposite to each other, the upper portions of the first side wall and the second side wall are both provided with the plasma inlet, and the lower portions of the first side wall and the second side wall are both provided with the waste liquid outlet.

[0011] Preferably, a second pump body is also provided on the plasma container.

[0012] Preferably, it further comprises a clamping platform, the clamping platform comprises a base, a fixing rod fixed above the base and a clamping portion fixed on the fixing rod, the clamping portion clamps and fixes the shell.

[0013] Preferably, the clamping portion comprises a connecting rod and two clamping arms, one end of the connecting rod is fixed to the fixing rod, and the other end is hinged to the roots of the two clamping arms, and the two clamping arms clamp the housing by moving closer to each other.

[0014] Preferably, at least two of the clamping parts are arranged in sequence from top to bottom, the plasma inlet and the cell outlet are located above the uppermost clamping part, and the waste liquid outlet and the cell inlet are located below the lowermost clamping part.

[0015] Preferably, the cell receiving container and the plasma container are detachably fixedly connected.

[0016] Preferably, the waste liquid container and the cell supply container are detachably fixedly connected.

[0017] The cell bioreactor provided by the utility model comprises a reactor body, the reactor body comprises an outer shell and a hollow fiber membrane arranged in the outer shell, the inner surface of the hollow fiber membrane has a positively charged cell adhesion layer; a cell inlet is arranged at the bottom of the outer shell, and a cell outlet is arranged at the top, the cell outlet and the cell inlet are both connected to the inner cavity of the hollow fiber membrane, the cell inlet is connected to a cell supply container, a first pump body is arranged on the cell supply container, and the cell inlet is connected to a cell receiving container; a plasma inlet and a waste liquid outlet are arranged on the side wall of the outer shell, the plasma inlet is connected to the plasma container, and the waste liquid outlet is connected to the waste liquid container.

[0018] During the bioartificial liver treatment, driven by the first pump body, the cell supply container can provide hepatocytes, specifically human hepatocytes or artificial hepatocytes, to the inner cavity of the hollow fiber membrane from bottom to top, so that the hepatocytes grow in the inner cavity of the hollow fiber membrane. During the movement of hepatocytes, since the cell membrane is mainly composed of a phospholipid bilayer, the surface of the cell membrane is negatively charged, and the positively charged cell adhesion layer attracts the hepatocytes to adhere to the surface of the inner cavity of the hollow fiber membrane, so that the hepatocytes can be evenly arranged on the inner surface of the hollow fiber membrane. In addition, since the first pump body drives the hepatocytes upward, the accumulation of hepatocytes at the bottom of the outer shell can also be avoided, which is conducive to the upward dispersion of the hepatocytes.

[0019] At the same time, the plasma in the plasma container flows through the outer cavity of the hollow fiber membrane, specifically, the gap between different hollow fiber membranes, and undergoes substance exchange and biological action with the hepatocytes evenly distributed in the inner cavity through the hollow fiber membrane. The waste liquid in the outer cavity is discharged into the waste liquid container, which can improve the stability of hepatocyte growth and culture, as well as the effect and efficiency of toxin treatment.

[0020] In addition, since hepatocytes grow in the inner cavity of the hollow fiber membrane and plasma flows in the outer cavity of the hollow fiber membrane, compared with the traditional structure in which plasma is located in the inner cavity and hepatocytes are located in the outer cavity, the problem of mutual interference between hepatocytes growing in the outer cavity, the outer shell and hepatocytes, and the hepatocytes in different membrane bundles during the growth and culture process can be avoided. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the utility model or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only embodiments of the utility model. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0022] Figure 1 This is a front view of a specific embodiment 1 of a cell bioreactor provided by the utility model;

[0023] Figure 2 A top view of the clamping portion of the first specific embodiment of the cell bioreactor provided by the utility model;

[0024] Figure 3 This is a structural diagram of a cell receiving container and a plasma container before connection in a specific embodiment 1 of a cell bioreactor provided by the utility model;

[0025] Figure 4 This is a structural diagram of a cell receiving container and a plasma container after being connected in a specific embodiment 1 of a cell bioreactor provided by the utility model;

[0026] Figure 5 This is a structural diagram of a cell supply container and a waste liquid container before connection in a specific embodiment 1 of a cell bioreactor provided by the utility model;

[0027] Figure 6 This is a structural diagram of a cell supply container and a waste liquid container after being connected in a specific embodiment 1 of a cell bioreactor provided by the utility model.

[0028] Reference numerals:

[0029] Reactor body 1, shell 11, cell inlet 111, cell outlet 112, plasma inlet 113, waste liquid outlet 114, hollow fiber membrane 12, inner cavity 121, outer cavity 122;

[0030] Cell supply container 2;

[0031] Cell receiving container 3;

[0032] Plasma container 4;

[0033] Waste liquid container 5;

[0034] Buckle 6;

[0035] The clamping platform 7 includes a base 71 , a fixing rod 72 , a clamping portion 73 , a clamping arm 731 , a spring 732 , a bolt 733 , and a connecting rod 734 . DETAILED DESCRIPTION

[0036] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0037] The core of the utility model is to provide a cell bioreactor, which can improve the stability of liver cell growth and culture, as well as the effect and efficiency of toxin treatment.

[0038] For a specific example of the cell bioreactor provided by the present invention, please refer to Figures 1 to 6 The reactor body 1 includes a shell 11 and a hollow fiber membrane 12 disposed in the shell 11. The inner surface of the hollow fiber membrane 12 has a positively charged cell adhesion layer. The inner surface of the hollow fiber membrane 12 is the surface surrounding the inner cavity 121 thereof.

[0039] The bottom of the housing 11 is provided with a cell inlet 111, and the top is provided with a cell outlet 112, the cell outlet 112 and the cell inlet 111 are both connected to the inner cavity 121 of the hollow fiber membrane 12, the cell inlet 111 is connected to the cell supply container 2, the cell supply container 2 is provided with a first pump body, and the cell outlet 112 is connected to the cell receiving container 3. Among them, the cell receiving container 3 can provide a liquid nitrogen environment, and the cell receiving container 3 can be provided with a flow meter.

[0040] The side wall of the housing 11 is provided with a plasma inlet 113 and a waste liquid outlet 114 connected to the outer cavity 122 of the hollow fiber membrane 12. The plasma inlet 113 is connected to the plasma container 4, and the waste liquid outlet 114 is connected to the waste liquid container 5. The plasma container 4 may have a heating part to replenish the outer cavity 122 with liquid.

[0041] During the bioartificial liver treatment, driven by the first pump body, the cell supply container 2 can provide liver cells, specifically human liver cells or artificial liver cells, to the inner cavity 121 of the hollow fiber membrane 12 from bottom to top, so that the liver cells grow in the inner cavity 121 of the hollow fiber membrane 12. During the movement of liver cells, since the cell membrane is mainly composed of a phospholipid bilayer, the surface of the cell membrane is negatively charged, and the positively charged cell adhesion layer attracts the liver cells to adhere to the surface of the inner cavity 121 of the hollow fiber membrane 12, so that the liver cells can be evenly arranged on the inner surface of the hollow fiber membrane 12. In addition, since the first pump body drives the liver cells upward, the accumulation of liver cells at the bottom of the shell 11 can also be avoided, which is conducive to the upward dispersion of the liver cells.

[0042] At the same time, the plasma in the plasma container 4 flows through the outer cavity 122 of the hollow fiber membrane 12, specifically, the gap between different hollow fiber membranes 12, and undergoes substance exchange and biological action with the hepatocytes evenly distributed in the inner cavity 121 through the hollow fiber membrane 12. The waste liquid in the outer cavity 122 is discharged into the waste liquid container 5, which can improve the stability of hepatocyte growth and culture, as well as the effect and efficiency of toxin treatment.

[0043] In addition, since hepatocytes grow in the inner cavity 121 of the hollow fiber membrane 12 and plasma flows in the outer cavity 122 of the hollow fiber membrane 12, compared with the traditional structure in which plasma is located in the inner cavity and hepatocytes are located in the outer cavity, the problem of mutual interference between the outer shell 11 and the hepatocytes and between the hepatocytes in different membrane bundles during the growth and culture process when the hepatocytes grow in the outer cavity 122 can be avoided.

[0044] Furthermore, the cell adhesion layer is a chitosan layer, which can provide a stable positive charge effect, effectively reduce the shedding of hepatocytes from the hollow fiber membrane 12, and the occurrence of unstable growth, increase the material exchange rate between hepatocytes and plasma, and improve the efficiency and stability of hepatocytes in processing plasma toxins. Among them, in order to achieve the fixation of the chitosan layer on the surface of the inner cavity 121, the specific process may include: weighing 98% of the water by mass fraction, pouring 1% chitosan powder and stirring evenly; dripping glacial acetic acid liquid while stirring and stirring for 5-10 minutes, and then standing for 1 hour; after standing, a 1% chitosan solution is obtained. Set the pump speed to 50ml / min, pump 800ml of 1% chitosan solution from the bottom of the cell bioreactor, and discharge it from the outlet directly above until the pump is finished. Then, the cell bioreactor treated with chitosan is placed in a 60-degree oven to make the chitosan adhere to the inner surface of the hollow fiber membrane 12, and modify the inner surface of the hollow fiber with chitosan.

[0045] Further, the arrangement of the plasma inlet 113 and the waste liquid outlet 114 is as follows: Figure 1 As shown, the waste liquid outlet 114 is lower than the plasma inlet 113. At this time, the movement directions of the plasma and the liver cells are opposite, which can improve the material exchange efficiency.

[0046] The housing 11 has a first side wall and a second side wall opposite to each other, the upper portions of the first side wall and the second side wall are both provided with a plasma inlet 113, and the lower portions of the first side wall and the second side wall are both provided with a waste liquid outlet 114. Figure 1 In the orientation shown, a total of six inlets or outlets are designed on the housing 11 of the cell bioreactor, respectively, at the top, bottom, upper left side, lower left side, upper right side, and upper right side. Through the arrangement of multiple plasma inlets 113 and multiple waste liquid outlets 114, plasma can be provided to the outer cavity 122 from different directions, so that plasma can more fully contact with liver cells at different positions in the inner cavity 121 and exchange substances.

[0047] Specifically, a second pump body is further provided on the plasma container 4. In addition to utilizing gravity, the second pump body can also be utilized to drive the movement of plasma in the outer cavity 122 to ensure the fluidity of the plasma.

[0048] Furthermore, if Figure 1 and Figure 2 As shown, the cell bioreactor also includes a clamping platform 7, which includes a base 71, a fixing rod 72 fixed above the base 71, and a clamping portion 73 fixed on the fixing rod 72. The clamping portion 73 clamps and fixes the outer shell 11 to facilitate maintaining the stability of the placement of the reactor body 1.

[0049] The base 71 can also be used to place instruments or equipment such as the cell supply container 2, the cell receiving container 3, the plasma container 4 and the waste liquid container 5 required for the cell biological reaction process.

[0050] The clamping part 73 includes a connecting rod 734 and two clamping arms 731, one end of the connecting rod 734 is fixed to the fixed rod 72, and the other end is hinged to the roots of the two clamping arms 731, and the two clamping arms 731 clamp the shell 11 by moving closer to each other. A spring 732 can be arranged between the two clamping arms 731, and the two clamping arms 731 can be moved away from each other by elastic force to facilitate the disassembly of the reactor body 1. In other embodiments, the two clamping arms 731 can also be brought closer by elastic force. In addition, the free ends of the two clamping arms 731 can be connected by bolts 733, so as to adjust the distance between the two clamping arms 731 according to the diameter of the reactor body 1. In addition, sponge layers are respectively arranged on the sides where the two clamping arms 731 are close to each other to protect the reactor body 1.

[0051] Among them, at least two clamping parts 73 are arranged in sequence from top to bottom, for example, two, to ensure stable clamping of the reactor body 1. The plasma inlet 113 and the cell outlet 112 are located above the uppermost clamping part 73, and the waste liquid outlet 114 and the cell inlet 111 are located below the lowermost clamping part 73. Since there is no inlet structure and outlet structure between the uppermost and lowermost clamping parts 73, the arrangement of the clamping part 73 can be avoided to interfere with the connection between the reactor body 1 and the plasma container 4 and the waste liquid container 5. In addition, when only one clamping part 73 is provided, the stability of clamping the reactor body 1 can be increased by increasing the area of ​​the clamping arm 731.

[0052] Furthermore, if Figure 3 and Figure 4 As shown, the cell receiving container 3 and the plasma container 4 are detachably fixedly connected, and can be specifically connected or plugged in by means of a buckle 6, so that the integrity of each container is ensured while the containers can be used flexibly. Specifically, the two plasma inlets 113 are respectively connected to a plasma container 4, and the two plasma containers 4 are respectively connected to the two sides of the cell receiving container 3.

[0053] Furthermore, if Figure 5 and Figure 6 As shown, the waste liquid container 5 and the cell supply container 2 are detachably fixedly connected. Specifically, the waste liquid container 5 and the cell supply container 2 can be plugged in or snapped in by a buckle 6, which ensures the integrity of each container and enables the containers to be used flexibly. In addition, the cell supply container 2, the plasma container 4, the waste liquid container 5, and the cell receiving container 3 can also be provided with labels, specifically, labels can be pasted.

[0054] The cell bioreactor in this embodiment has the following working principles: the first pump body uses a certain pump speed to first inject the liver cells into the inner cavity 121 of the hollow fiber membrane 12 in the cell bioreactor at a certain flow rate, and under the action of chitosan on the inner surface of the hollow fiber membrane 12, the liver cells adhere to the inner surface of the hollow fiber membrane 12, and then, at the plasma inlet 113 on the upper left side and the upper right side, the plasma with a certain temperature is pumped into the outer cavity 122 of the hollow fiber membrane 12 through the action of the second pump body, so that the plasma flows evenly through the outer surface of the left and right hollow fiber membranes 12. Through continuous fluid infusion, plasma is continuously injected from the plasma inlet 113 on the upper left and upper right sides, continuously providing nutrients for the growth and reproduction of liver cells in the inner cavity 121 of the hollow fiber membrane 12, and at the same time, the liver cells can continuously metabolize and decompose toxins for plasma. The treated plasma is discharged from the waste liquid outlet 114 on the lower left and lower right sides, and the artificial liver cells are discharged from the cell outlet 112 above, and then stored in a low-temperature liquid nitrogen environment, waiting for use.

[0055] It should be noted that when an element is referred to as "fixed" to another element, it may be directly on the other element or there may be an element in the middle. When an element is considered to be "connected" to another element, it may be directly connected to the other element or there may be an element in the middle at the same time. In addition, in the description of the present utility model, unless otherwise specified, "multiple", "multiple roots", and "multiple groups" mean two or more.

[0056] The terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc. indicate positions or positional relationships based on the positions or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific position, be constructed and operated in a specific position, and therefore cannot be understood as limiting the present invention. In addition, the terms "first", "second", and "third" are only used for descriptive purposes, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features.

[0057] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0058] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0059] The cell bioreactor provided by the utility model is introduced in detail above. The principle and implementation method of the utility model are described in this article using specific examples. The description of the above examples is only used to help understand the method and core idea of ​​the utility model. It should be pointed out that for ordinary technicians in this technical field, without departing from the principle of the utility model, the utility model can also be improved and modified, and these improvements and modifications also fall within the scope of protection of the claims of the utility model.

Claims

1. A cell bioreactor, characterized in that: The reactor body (1) comprises a shell (11) and a hollow fiber membrane (12) arranged in the shell (11), wherein the inner surface of the hollow fiber membrane (12) has a positively charged cell adhesion layer; a cell inlet (111) is arranged at the bottom of the shell (11), and a cell outlet (112) is arranged at the top; the cell outlet (112) and the cell inlet (111) are both connected to the inner cavity (121) of the hollow fiber membrane (12); The cell inlet (111) is connected to a cell supply container (2), a first pump body is arranged on the cell supply container (2), and the cell outlet (112) is connected to a cell receiving container (3); the side wall of the shell (11) is provided with a plasma inlet (113) and a waste liquid outlet (114) which are connected to the outer cavity (122) of the hollow fiber membrane (12), the plasma inlet (113) is connected to a plasma container (4), and the waste liquid outlet (114) is connected to a waste liquid container (5).

2. The cell bioreactor according to claim 1, characterized in that The cell adhesion layer is a chitosan layer.

3. The cell bioreactor according to claim 1, characterized in that The waste liquid outlet (114) is lower than the plasma inlet (113).

4. The cell bioreactor according to claim 3, characterized in that: The housing (11) has a first side wall and a second side wall opposite to each other, the upper portions of the first side wall and the second side wall are both provided with the plasma inlet (113), and the lower portions of the first side wall and the second side wall are both provided with the waste liquid outlet (114).

5. The cell bioreactor according to claim 3, characterized in that: A second pump body is also arranged on the plasma container (4).

6. The cell bioreactor according to any one of claims 1 to 5, characterized in that: It also comprises a clamping platform (7), the clamping platform (7) comprising a base (71), a fixing rod (72) fixed above the base (71), and a clamping portion (73) fixed on the fixing rod (72), the clamping portion (73) clamping and fixing the housing (11).

7. The cell bioreactor according to claim 6, characterized in that The clamping portion (73) comprises a connecting rod (734) and two clamping arms (731); one end of the connecting rod (734) is fixed to the fixing rod (72), and the other end is hinged to the roots of the two clamping arms (731); the two clamping arms (731) clamp the housing (11) by moving closer to each other.

8. The cell bioreactor according to claim 7, characterized in that: At least two of the clamping parts (73) are arranged in sequence from top to bottom, the plasma inlet (113) and the cell outlet (112) are located above the uppermost clamping part (73), and the waste liquid outlet (114) and the cell inlet (111) are located below the lowermost clamping part (73).

9. The cell bioreactor according to any one of claims 1 to 5, characterized in that: The cell receiving container (3) and the plasma container (4) are detachably fixedly connected.

10. The cell bioreactor according to any one of claims 1 to 5, characterized in that: The waste liquid container (5) and the cell supply container (2) are detachably fixedly connected.